| Julie Brown |
Julie Brown is currently the Director at F. Hoffmann-La Roche Ltd. and the Chief Financial Officer & Executive Director at GSK Plc. She is also a Member of the Institute of Chartered Accountants in England & Wales and the Taxation Institute of London. In addition, she is a Member of The Prime Minister's Business Advisory Group. Previously, she held positions such as Independent Non-Executive Director at Roche Holding AG, Chief Financial Officer & Executive Director at Smith & Nephew plc, Director, Chief Operating & Financial Officer at Burberry Group Plc, and Chief Financial Officer at AstraZeneca PLC. She was also a Non-Executive Director at the National Health Service. She started her career as a Manager-Licensing & Commercial Finance at Imperial Chemical Industries Ltd. and later became the Head-Finance Department at Zeneca Garden Care. She also served as the Head-Marketing at Astrazeneca Produtos Farmaceuticos Ltda. Ms. Brown received her undergraduate degree from the University of Warwick in 1983. |
| Shobie Ramakrishnan |
Shobie Ramakrishnan is currently the Chief Digital & Technology Officer at GSK Plc and an Independent Non-Executive Officer at Deliveroo Plc. She previously worked as a Director at Remediant, Inc. and SustainableIT.org, Inc. Ms. Ramakrishnan completed her undergraduate degree at VIT University. |
| MarÃa Cristina de Luna Basagoiti |
MarÃa Cristina de Luna Basagoiti is currently an Independent Director at Meliá Hotels International SA, an Independent Director at Viscofán SA, and an Independent Non-Executive Director at Applus Services SA. She is also a Director at Desarrollo Energia Solar Alternativa SL. Previously, she worked as the General Manager-Spain at GSK Plc and as a Member-Governors Board & Vice-President at Farmaindustria. Ms. de Luna Basagoiti has also served as a Trustee at Fondazione Cotec, a Trustee at Seres Foundation, and as Vice President at Fundación De Ciencias De La Salud and Fundación España Salud. Additionally, she has been a Trustee at Fundación Sociedad y Empresa Responsable. Prior to her current and former positions, Ms. de Luna Basagoiti worked as the General Director-Finances & Accounts at Procter & Gamble Co. from 2006 to 2010. She holds an undergraduate degree from Instituto Catolico de Administracion y Direccion de Empresas and Universidad Pontificia Comillas. |
| Tony Wood |
Tony Wood is currently the Director at The Rosalind Franklin Institute and the Chief Scientific Officer at GSK Plc. Previously, he worked as the Senior VP-Medicinal Science & Technology at Pfizer Ltd. He obtained his undergraduate and doctorate degrees from The University of Newcastle. |
| James Ford |
James Ford currently works at Civil Justice Reform Group, as Co-Chairman, European General Counsel Association, as Director, GSK Plc, as Group General Counsel, Head-Legal & Compliance from 2018, New York State Bar Association, as Attorney, and Association of General Counsel, as Member. Mr. Ford also formerly worked at Association of Corporate Counsel Singapore, as President from 2016 to 2017. Mr. Ford received his graduate degree from the University of East Anglia. |
| Diana Conrad |
Diana Conrad is currently working as the Chief People Officer at GSK Plc. She started this position in 2019. Ms. Conrad completed her undergraduate degree at McMaster University. |
| Amy Altshul |
Amy Altshul has worked in the past for GSK Plc as SVP-Legal, Research & Development. Currently, she holds the position of Director at Galvani Bioelectronics Ltd. |
| Emma N. Walmsley |
Emma N. Walmsley is currently the Chief Executive Officer & Executive Director at GSK Plc since 2017. She is also the Chief Executive Officer at GlaxoSmithKline Australia Pty Ltd. Additionally, she serves as an Independent Director at Microsoft Corp. and as a Member at Stanford Medicine. Previously, Ms. Walmsley held the position of Chief Executive Officer at GlaxoSmithKline Consumer Healthcare Pte Ltd. and GlaxoSmithKline Consumer Healthcare Holdings Ltd. She was also a Non-Executive Director at Diageo Plc in 2016. Furthermore, she worked as the General Manager-Consumer Products at L'Oreal (China) Co., Ltd.Ms. Walmsley completed her graduate degree at the University of Oxford. |
| David Simon Redfern |
David Simon Redfern is currently the Chairman at ViiV Healthcare Ltd., Director at Human Genome Sciences, Inc., Non-Executive Director at Aspen Pharmacare Holdings Ltd., and Director at GlaxoSmithKline Consumer Healthcare Holdings Ltd. He previously served as the President-Corporate Development at GSK Plc. Prior to his current positions, he was a Director at Haleon UK Holdings (No.2) Ltd. and a Principal at PricewaterhouseCoopers Services Ltd. Mr. Redfern obtained his undergraduate degree from the University of Bristol. |
| Hal V. Barron |
Hal V. Barron is currently the Co-Chairman & Chief Executive Officer at Altos Labs, Inc. He is also a Non-Independent Non-Executive Director at GSK Plc and a Non-Executive Director at GRAIL LLC. In addition, he holds positions as a Cardiologist at UCSF Medical Center and as an Adjunct Professor at The University of California, San Francisco. Previously, Barron served as an Independent Director at Alexza Pharmaceuticals, Inc. from 2011 to 2013. He was also a Director & Senior Vice President-Development at Arête Therapeutics, Inc. Furthermore, he held the position of Independent Non-Executive Director at Juno Therapeutics, Inc. from 2014 to 2018. Prior to that, he was the Chief Medical Officer & EVP-Global Development at Genentech, Inc. from 2010 to 2013 and at F. Hoffmann-La Roche Ltd. from 2010 to 2013. He also served as the Chief Medical Officer & Executive Vice President at Roche Pharmaceuticals, Inc. Additionally, he was the President at Tesaro, Inc. and held the position of President-Research & Development at Calico LLC from 2013 to 2017. Barron received his undergraduate degree from Washington University in St. Louis in 1985 and his doctorate degree from Yale University in 1989. |
| Jonathan Richard Symonds |
Jonathan Richard Symonds is the founder of Oxford University Centre for Business Taxation. He currently holds the position of Non-Executive Chairman at GSK Plc and Non-Executive Director at Genomics England Ltd. He also serves as the Head of Corporate Finance & Strategy at Mesoblast Ltd. Additionally, he is a Member of the Governors Board at Harrow School and a Member of the European Round Table For Industry. In his former roles, Mr. Symonds served as the Deputy Group Chairman at HSBC Holdings Plc from 2018 to 2020 and as the Chairman of HSBC Bank Plc from 2014 to 2018. He was also the Chairman of Innocoll, Inc., Innocoll AG, and The 100 Group. Furthermore, he held the position of Chairman-Supervisory Board at Innocoll Holdings Plc from 2014 to 2017. He served as a Non-Executive Director at Diageo Plc from 2004 to 2007 and as a Managing Director at The Goldman Sachs Group, Inc. from 2007 to 2009. He was an Independent Director at Proteus Digital Health, Inc. and a Non-Executive Director at QinetiQ Group plc. He also held the position of Director-Finance at Zeneca Group Plc and Director at the Accounting Standards Board. Mr. Symonds's education includes an undergraduate degree from the University of Hertfordshire, which was conferred in 1980. |
| Maya Martinez-Davis |
Maya Martinez-Davis is currently the President-US Pharmaceuticals at GSK Plc. Prior to this, she was the Independent Director at Mirati Therapeutics, Inc. from 2018 to 2024 and the President-Biopharma Latin America at Merck KGaA from 2016 to 2019. She completed her undergraduate degree at St. Louis University and her graduate degree at Instituto de Empresa SL. |
| Philip Thomson |
Philip Thomson is currently the Chairman of The Whitehall & Industry Group and the Director of the China-Britain Business Council. He is also the President-Global Affairs at GSK Plc, a position he has held since 2017. Previously, he worked as the Director of Media Relations at Glaxo Wellcome Plc from 1996 to 2001. Mr. Thomson completed his undergraduate degree at the University of Durham. |
| Luke Miels |
Luke Miels is currently a Director at ViiV Healthcare Co., Chief Commercial Officer at GSK Plc, and a Member at Singapore Economic Development Board. Previously, he held positions as Executive VP-Global Portfolio & Product Strategy at AstraZeneca PLC and Regional VP-Asia Pacific & Pharmaceuticals Division at Roche Pharmaceuticals, Inc. Mr. Miels has an MBA from Macquarie University and an undergraduate degree from Flinders University. |
| Regis Jean-Pierre Simard |
Regis Jean-Pierre Simard is currently the Director at ViiV Healthcare Ltd. and the President-Global Supply Chain at GSK Plc. Previously, he served as the Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd. from 2015 to 2017. He also held a position as Director at Glaxo Operations UK Ltd. |
